µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© g(& hu S
]{^'{ z$i
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© l!qhK'']V"
1.Co-stimulators (or co-stimulating molecules) Xt}
4B#
2.NK-kB &6wD
3.Immunoglobulin superfamily 5nF46c
4.antigen-presenting cell (APC) ua%@Ay1|
5.death domain [ICFPY6
6.CCR and CXCR #0kVhx7%
7.Lectin (or mitogen) 8z1#Q#5
8.Clusters of differentiation, CD) 3u[m? Vw
9.B7 family n#$sLXVy
10.Cytotoxic T lymphocyte, CTL) L)(JaZy
V5
11.IL-15 and IL-15 receptor (IL-15R) Jt++3]
12.MHC restriction ahICx{hK
13.Affinity-chromatography !WSY75
14.Cyctosprin A, CsA {'#1do}{
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) :Oiz|b(
1
1VtC)
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© JkShtLEr
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 )fy-]Ky
*
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ /O[<"Wcz
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ yE&WGpT
/
f5q9sp8
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© _^/k
&2,3R}B/
ÃâÒßѧרҵ£º \E(^<Af
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ u4#YZOiY)A
dzQs7D}
Ïû»¯ÄÚ¿Æ£º efr 9
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ n!-]f.=P
l"zA~W/
ѪҺ²¡Ñ§×¨Òµ£º ?:tk8Kgf
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿